Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

AstraZeneca PLC (AZN)

-NYSE
71.79 Down 1.34(1.83%) Apr 24, 4:00PM EDT
Add to Portfolio
Prev Close:73.13
Open:71.29
Bid:70.88 x 1000
Ask:72.30 x 200
1y Target Est:75.97
Beta:0.89
Next Earnings Date:N/A
Day's Range:71.05 - 72.43
52wk Range:64.26 - 82.68
Volume:1,876,868
Avg Vol (3m):1,537,860
Market Cap:90.68B
P/E (ttm):73.48
EPS (ttm):0.98
Div & Yield:3.80 (5.50%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 1.83%90.68B
GSKUp 0.60%112.07B
MRKUp 0.16%162.92B
PFEDown 0.25%216.57B

Key Statistics

Forward P/E (1 yr):17.73
P/S (ttm):3.54
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :4.20
Quarterly EPS Est (Jun-15) :1.02
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):5.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback